跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATORVASTATINA BLUEFISH 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ATORVASTATINA BLUEFISH 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ATORVASTATINA BLUEFISH 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Bluefish Pharmaceuticals Ab (Publ)
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 21, 2021
Approval ID
b83437dde56b26d8
Company
Bluefish Pharmaceuticals Ab (Publ)
Type
Standard
Approval Details
Approval Id
b83437dde56b26d8
Drug Cima Aemps Name
ATORVASTATINA BLUEFISH 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
86211
Holder Company Name
Bluefish Pharmaceuticals Ab (Publ)
Marketing Company Name
Bluefish Pharma S.L.U.
Authorization Date
2021-09-21
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
30 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Bluefish Pharmaceuticals Ab (Publ)
Active Ingredients
ATORVASTATINA CALCICA TRIHIDRATO
31,02 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 21, 2021
Approval ID
b83437dde56b26d8
Type
Standard
Back to CIMA-AEMPS Approvals